Real-time Estimate
Cboe Europe
05:13:39 2024-06-10 am EDT
|
5-day change
|
1st Jan Change
|
727.4
GBX
|
-0.57%
|
|
-3.63%
|
-17.97%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
37,555
|
34,995
|
34,858
|
30,859
|
24,317
|
20,049
|
-
|
-
|
Enterprise Value (EV)
1 |
38,829
|
34,995
|
34,858
|
30,859
|
24,317
|
20,049
|
20,049
|
20,049
|
P/E ratio
|
61.9
x
|
23
x
|
-21.5
x
|
37.5
x
|
18.2
x
|
9.85
x
|
8.83
x
|
8.06
x
|
Yield
|
2.49%
|
1.2%
|
1.03%
|
1.34%
|
-
|
2.42%
|
2.65%
|
2.94%
|
Capitalization / Revenue
|
1.12
x
|
4.73
x
|
2.04
x
|
1.75
x
|
-
|
1
x
|
0.82
x
|
0.92
x
|
EV / Revenue
|
1.12
x
|
4.73
x
|
2.04
x
|
1.75
x
|
-
|
1
x
|
0.82
x
|
0.92
x
|
EV / EBITDA
|
-
|
8,888,582
x
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.92
x
|
1.68
x
|
2.58
x
|
2.28
x
|
-
|
1.25
x
|
1.11
x
|
1.03
x
|
Nbr of stocks (in thousands)
|
2,591,753
|
2,597,990
|
2,735,012
|
2,736,969
|
2,740,921
|
2,740,428
|
-
|
-
|
Reference price
2 |
14.49
|
13.47
|
12.74
|
11.28
|
8.872
|
7.316
|
7.316
|
7.316
|
Announcement Date
|
3/11/20
|
3/3/21
|
3/9/22
|
3/15/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
33,606
|
7,391
|
17,090
|
17,615
|
-
|
20,098
|
24,569
|
21,690
|
EBITDA
|
-
|
3,937
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
4,104
|
3,947
|
2,470
|
2,778
|
2,274
|
2,853
|
3,010
|
3,130
|
Operating Margin
|
12.21%
|
53.4%
|
14.45%
|
15.77%
|
-
|
14.19%
|
12.25%
|
14.43%
|
Earnings before Tax (EBT)
1 |
1,768
|
1,540
|
2,305
|
1,220
|
1,648
|
2,594
|
2,741
|
3,089
|
Net income
1 |
605.2
|
1,518
|
-1,560
|
821.4
|
1,337
|
2,090
|
2,225
|
2,474
|
Net margin
|
1.8%
|
20.54%
|
-9.13%
|
4.66%
|
-
|
10.4%
|
9.05%
|
11.41%
|
EPS
2 |
0.2342
|
0.5848
|
-0.5935
|
0.3004
|
0.4866
|
0.7424
|
0.8282
|
0.9073
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3605
|
0.1610
|
0.1308
|
0.1508
|
-
|
0.1769
|
0.1942
|
0.2150
|
Announcement Date
|
3/11/20
|
3/3/21
|
3/9/22
|
3/15/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2021 S2
|
2022 Q1
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
2025 S1
|
2025 S2
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
3,050
|
3,062
|
3,335
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
2,599
|
1,943
|
1,133
|
1,270
|
-
|
1,374
|
1,411
|
-
|
-
|
1,365
|
1,271
|
1,462
|
1,409
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
44.76%
|
41.51%
|
43.83%
|
-
|
Earnings before Tax (EBT)
|
628.3
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-970.9
|
-
|
-2,892
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-0.2910
|
0.1970
|
-
|
0.5844
|
-
|
0.0314
|
0.2692
|
0.2734
|
0.2154
|
0.4170
|
0.3930
|
0.4480
|
0.4320
|
Dividend per Share
1 |
0.1960
|
0.0410
|
0.0387
|
-
|
0.0245
|
0.0468
|
0.1047
|
0.0492
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/11/20
|
8/11/20
|
8/11/21
|
3/9/22
|
5/10/22
|
8/10/22
|
3/15/23
|
8/30/23
|
3/20/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
1,274
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
21.9%
|
22.6%
|
14.1%
|
16.2%
|
-
|
13.3%
|
13.2%
|
13.6%
|
ROA (Net income/ Total Assets)
|
0.82%
|
0.94%
|
0.75%
|
1.51%
|
-
|
1.4%
|
1.48%
|
1.44%
|
Assets
1 |
73,639
|
161,542
|
-209,058
|
54,519
|
-
|
149,180
|
149,936
|
172,298
|
Book Value Per Share
2 |
7.530
|
8.040
|
4.930
|
4.950
|
-
|
5.850
|
6.570
|
7.100
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/11/20
|
3/3/21
|
3/9/22
|
3/15/23
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
7.316
GBP Average target price
12.3
GBP Spread / Average Target +68.10% Consensus |
1st Jan change
|
Capi.
|
---|
| -17.91% | 25.51B | | +7.62% | 50.45B | | +5.93% | 49.81B | | +21.55% | 46.31B | | +13.62% | 42.31B | | +23.63% | 39.83B | | -1.75% | 28.46B | | -8.98% | 27.07B | | +27.21% | 26.32B | | +39.17% | 24.17B |
Other Life & Health Insurance
|